Depsipeptides Targeting Tumor Cells: Milestones from In Vitro to Clinical Trials
Molecules · 2023
DOI: 10.3390/molecules28020670 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Plinio A Trinidad-Calderón und 2 weiteren Autor:innen. Beteiligte Einrichtung: Tecnológico de Monterrey, School of Engineering, and Sciences, Avenida Eugenio Garza Sada 2501, Monterrey 64849, Nuevo León, Mexico. Hauptthemen laut MEDLINE: Depsipeptides, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 252 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CONACyT, Tecnologico de Monterrey.
Abstract (Originalsprache)
Cancer is currently considered one of the most threatening diseases worldwide. Diet could be one of the factors that can be enhanced to comprehensively address a cancer patient’s condition. Unfortunately, most molecules capable of targeting cancer cells are found in uncommon food sources. Among them, depsipeptides have emerged as one of the most reliable choices for cancer treatment. These cyclic amino acid oligomers, with one or more subunits replaced by a hydroxylated carboxylic acid resulting in one lactone bond in a core ring, have broadly proven their cancer-targeting efficacy, some even reaching clinical trials and being commercialized as “anticancer” drugs. This review aimed to describe these depsipeptides, their reported amino acid sequences, determined structure, and the specific mechanism by which they target tumor cells including apoptosis, oncosis, and elastase inhibition, among others. Furthermore, we have delved into state-of-the-art in vivo and clinical trials, current methods for purification and synthesis, and the recognized disadvantages of these molecules. The information collated in this review can help researchers decide whether these molecules should be incorporated into functional foods in the near future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tecnológico de Monterrey, School of Engineering, and Sciences, Avenida Eugenio Garza Sada 2501, Monterrey 64849, Nuevo León, Mexico.
ORCID-Profile: Plinio A Trinidad-Calderón, Carlos Daniel Varela-Chinchilla, Silverio García-Lara
Förderung
- CONACyT
- Tecnologico de Monterrey
Zitieren
APA
Trinidad-Calderón, P. A., Varela-Chinchilla, C. D., & García-Lara, S. (2023). Depsipeptides Targeting Tumor Cells: Milestones from In Vitro to Clinical Trials. Molecules. https://doi.org/10.3390/molecules28020670
Vancouver
Trinidad-Calderón PA, Varela-Chinchilla CD, García-Lara S. Depsipeptides Targeting Tumor Cells: Milestones from In Vitro to Clinical Trials. Molecules. 2023. doi:10.3390/molecules28020670
BibTeX
@article{TrinidadCaldern2023,
author = {Trinidad-Calderón, Plinio A and Varela-Chinchilla, Carlos Daniel and García-Lara, Silverio},
title = {Depsipeptides Targeting Tumor Cells: Milestones from In Vitro to Clinical Trials},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28020670}
}
EUVIMED